Tasly Pharmaceutical Group Co Ltd (600535) — Long-term Investment Intensity
Tasly Pharmaceutical Group Co Ltd (600535) has a Long-term Investment Intensity of 4.8% as of September 2019. Long-term investments of CN¥1.18 Billion represent 4.8% of total assets of CN¥24.41 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Tasly Pharmaceutical Group Co Ltd (600535) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Tasly Pharmaceutical Group Co Ltd Long-term Investment Intensity (2015–2018)
This chart shows how Tasly Pharmaceutical Group Co Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2015 to 2018. As of September 2019, the intensity stands at 4.8%, reflecting long-term investments of CN¥1.18 Billion against total assets of CN¥24.41 Billion CNY. For the complete balance sheet picture, see balance sheet size of Tasly Pharmaceutical Group Co Ltd.
Annual Long-term Investment Intensity for Tasly Pharmaceutical Group Co Ltd (2015–2018)
The table below presents the year-by-year Long-term Investment Intensity for Tasly Pharmaceutical Group Co Ltd from 2015 to 2018, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read how much debt does Tasly Pharmaceutical Group Co Ltd carry for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (CNY) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 5.4% | CN¥1.36 Billion | CN¥25.17 Billion | ▲ +0.5 pp |
| 2017 | 4.9% | CN¥1.05 Billion | CN¥21.53 Billion | ▲ +0.9 pp |
| 2016 | 4.0% | CN¥684.61 Million | CN¥17.13 Billion | ▲ +0.6 pp |
| 2015 | 3.4% | CN¥530.32 Million | CN¥15.41 Billion | — |